89 related articles for article (PubMed ID: 26767599)
1. Bethesda 2014: improving on a paradigm shift.
Wilbur DC; Nayar R
Cytopathology; 2015 Dec; 26(6):339-42. PubMed ID: 26767599
[TBL] [Abstract][Full Text] [Related]
2. Two-grade Bethesda system of reporting in cervical screening: colposcopist's view.
Prendiville W
Cytopathology; 2015 Dec; 26(6):351-3. PubMed ID: 26767602
[No Abstract] [Full Text] [Related]
3. Is it time for a unified two-tier reporting system for cervical cytology and histology in the cervical screening programmes?
Smith JH
Cytopathology; 2015 Dec; 26(6):337-8. PubMed ID: 26767598
[No Abstract] [Full Text] [Related]
4. The terminology of pre-invasive cervical lesions in the UK cervical screening programme.
Herrington CS
Cytopathology; 2015 Dec; 26(6):346-50. PubMed ID: 26767601
[TBL] [Abstract][Full Text] [Related]
5. The Bethesda System. A proposal for reporting abnormal cervical smears based on the reproducibility of cytopathologic diagnoses.
Sherman ME; Schiffman MH; Erozan YS; Wacholder S; Kurman RJ
Arch Pathol Lab Med; 1992 Nov; 116(11):1155-8. PubMed ID: 1444745
[TBL] [Abstract][Full Text] [Related]
6. The Pap Test and Bethesda 2014. "The reports of my demise have been greatly exaggerated." (after a quotation from Mark Twain).
Nayar R; Wilbur DC
Acta Cytol; 2015; 59(2):121-32. PubMed ID: 25997404
[TBL] [Abstract][Full Text] [Related]
7. European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1.
Jordan J; Arbyn M; Martin-Hirsch P; Schenck U; Baldauf JJ; Da Silva D; Anttila A; Nieminen P; Prendiville W
Cytopathology; 2008 Dec; 19(6):342-54. PubMed ID: 19040546
[TBL] [Abstract][Full Text] [Related]
8. The Pap Test and Bethesda 2014: "The reports of my demise have been greatly exaggerated. (after a quotation from Mark Twain)".
Nayar R; Wilbur DC
J Low Genit Tract Dis; 2015 Jul; 19(3):175-84. PubMed ID: 25943863
[TBL] [Abstract][Full Text] [Related]
9. From Papanicolaou to Bethesda: the rationale for a new cervical cytologic classification.
Kurman RJ; Malkasian GD; Sedlis A; Solomon D
Obstet Gynecol; 1991 May; 77(5):779-82. PubMed ID: 1849626
[TBL] [Abstract][Full Text] [Related]
10. [New nomenclature in gynecologic cytology].
Breitenecker G; Dinges HP; Gitsch G
Gynakol Rundsch; 1990; 30 Suppl 1():162-4. PubMed ID: 2079254
[No Abstract] [Full Text] [Related]
11. Terms without borders: an international approach to terminology.
Herbert DA
Diagn Cytopathol; 2005 Nov; 33(5):352-5. PubMed ID: 16240399
[TBL] [Abstract][Full Text] [Related]
12. The Bethesda system for the reporting of cervical/vaginal cytology.
Oren A; Fernandes J
J Am Osteopath Assoc; 1991 May; 91(5):476-9. PubMed ID: 2061103
[TBL] [Abstract][Full Text] [Related]
13. Incidence and evaluation of an AGUS Papanicolaou smear in primary care.
Valdini A; Vaccaro C; Pechinsky G; Abernathy V
J Am Board Fam Pract; 2001; 14(3):172-7. PubMed ID: 11355048
[TBL] [Abstract][Full Text] [Related]
14. Preventing cervical cancer: the role of the Bethesda system.
Shepherd JC; Fried RA
Am Fam Physician; 1995 Feb; 51(2):434-40, 443-4. PubMed ID: 7840040
[TBL] [Abstract][Full Text] [Related]
15. Abnormal cervical cytology: new names, familiar smears.
Carulli DT
J Am Acad Nurse Pract; 2003 Oct; 15(10):444-9. PubMed ID: 14606133
[TBL] [Abstract][Full Text] [Related]
16. The Bethesda system and Pap smear screening.
Miller K
Am Fam Physician; 1995 Feb; 51(2):331-2. PubMed ID: 7840027
[No Abstract] [Full Text] [Related]
17. ABC3 Part I: a review of the guidelines for terminology, classification and management of cervical cytology in England.
Smith JH
Cytopathology; 2012 Dec; 23(6):353-9. PubMed ID: 23173804
[TBL] [Abstract][Full Text] [Related]
18. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia.
Liao SY; Stanbridge EJ
Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):549-57. PubMed ID: 8827360
[TBL] [Abstract][Full Text] [Related]
19. Problems encountered with the Bethesda System: the University of Iowa experience.
Bottles K; Reiter RC; Steiner AL; Zaleski S; Bedrossian CW; Johnson SR
Obstet Gynecol; 1991 Sep; 78(3 Pt 1):410-4. PubMed ID: 1876375
[TBL] [Abstract][Full Text] [Related]
20. Morphologic scales and relative distances between lesions identified on Papanicolaou smears.
Okagaki T; Lau M; Brooker DC; Zelterman D
Anal Quant Cytol Histol; 1992 Aug; 14(4):335-40. PubMed ID: 1388571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
